tirzepatide vs semaglutide pancreatitis emerge health Weight-loss injections are everywhere right now. But there's a side of the Semaglutide vs Tirzepatide: Which Is

Women with type 2 diabetes mellitus or pre-diabetes associated with obesity/overweight (the treatment sometimes manages to reverse the metabolic alteration completely after weight loss)

Semaglutide-based drugs (Ozempic, Wegovy) and tirzepatide-based drugs (Mounjaro) are generally more effective for weight loss than other GLP-1 agonists like dulaglutide or liraglutide, according to comparative trial data

Put simply: tirzepatide tends to shift body composition in a favorable direction, but protecting muscle still takes work

Consequently, it aids in weight loss

Patients want alternatives to long-term steroid use GLP-1 modulation may offer a pathway to reduced inflammation without the side effects of immunosuppressants

At 72 weeks, Tirzepatide produced 20.2% average weight loss compared to 13.7% for Semaglutide